The Hattangadi-Gluth Lab explores advanced MR imaging techniques to improve the treatment of brain tumors, and investigates novel imaging biomarkers to measure response to radiation in brain tissue. A second focus is on health policy, particularly the impact of regulatory and legal issues on the practice of medicine. Dr. Hattangadi-Gluth and colleagues have performed analyses of FDA regulation of medical devices, the impact of medical malpractice claims related to radiation therapy, and on financial conflicts of interest among physicians.
Dr. Hattangadi-Gluth is the principal investigator of several investigator-initiated clinical trials, including a longitudinal study of advanced diffusion imaging and serial neurocognitive testing to measure radiation-induced injury in brain tumor patients. She holds extensive grant funding, including a KL2/NIH career development award. Dr. Hattangadi-Gluth also does research in health outcomes and health policy and has published extensively in these areas.